Drugs of abuse and kidney toxicity

2021 Dias da Silva, 2021, Neurotoxicity of psychoactive substances: a mechanistic overview, Curr. Opin. Toxicol., 28, 76, 10.1016/j.cotox.2021.10.002 Pendergraft, 2014, Nephrotoxic effects of common and emerging drugs of abuse, Clin J Am Soc Nephrol, 9, 1996, 10.2215/CJN.00360114 Sari, 2019, Nephrotoxic effects of drugs Kwiatkowska, 2021, The mechanism of drug nephrotoxicity and the methods for preventing kidney damage, Int J Mol Sci, 22, 6109, 10.3390/ijms22116109 Mansoor, 2017, Systematic review of nephrotoxicity of drugs of abuse, 2005-2016, BMC Nephrol, 18, 379, 10.1186/s12882-017-0794-0 Tam, 2016, The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases, J Basic Clin Physiol Pharmacol, 27, 267 2021 Ho, 2019, A review of cannabis in chronic kidney disease symptom management, Can. J. Kidney Health Dis., 6, 10.1177/2054358119828391 Bhanushali, 2013, AKI associated with synthetic cannabinoids: a case series, Clin J Am Soc Nephrol, 8, 523, 10.2215/CJN.05690612 2013, Acute kidney injury associated with synthetic cannabinoid use - multiple states, MMWR (Morb Mortal Wkly Rep), 62, 93 Alp, 2017, Synthetic cannabinoids in the kidneys, Rev Assoc Med Bras, 63, 10, 10.1590/1806-9282.63.01.10 Silva, 2018, The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis, Toxicol Lett, 287, 59, 10.1016/j.toxlet.2018.01.023 Silva, 2019, Synthetic cannabinoids JWH-122 and THJ-2201 disrupt endocannabinoid-regulated mitochondrial function and activate apoptotic pathways as a primary mechanism of in vitro nephrotoxicity at in vivo relevant concentrations, Toxicol Sci, 169, 422, 10.1093/toxsci/kfz050 Goel, 2014, Cocaine and kidney injury: a kaleidoscope of pathology, Clin. Kidney J., 7, 513, 10.1093/ckj/sfu092 Jaffe, 2006, Chronic nephropathies of cocaine and heroin abuse: a critical review, Clin J Am Soc Nephrol, 1, 655, 10.2215/CJN.00300106 Filho, 2019, Spectrum of acute kidney injury associated with cocaine use: report of three cases, BMC Nephrol, 20, 99, 10.1186/s12882-019-1279-0 Inayat, 2020, Cocaine-induced acute interstitial nephritis: a comparative review of 7 cases, J. Investig. Med. High Impact Case Rep., 8 Valente, 2012, Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells, Arch Toxicol, 86, 249, 10.1007/s00204-011-0749-3 Dettmeyer, 2005, Heroin-associated nephropathy, Expet Opin Drug Saf, 4, 19, 10.1517/14740338.4.1.19 Bautista, 2015, Heroin crystal nephropathy, Clinical kidney journal, 8, 339, 10.1093/ckj/sfv018 Manner, 2009, Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure, Clin Nephrol, 72, 224, 10.5414/CNP72224 Sahni, 2008, Unusual complications of heroin abuse: transverse myelitis, rhabdomyolysis, compartment syndrome, and ARF, Clin Toxicol, 46, 153, 10.1080/15563650701639071 Golosova, 2020, Role of opioid signaling in kidney damage during the development of salt-induced hypertension, Life Sci. Alliance, 3, 10.26508/lsa.202000853 Weber, 2008, Morphine induces mesangial cell proliferation and glomerulopathy via κ-opioid receptors, Am J Physiol Ren Physiol, 294, F1388, 10.1152/ajprenal.00389.2007 Patel, 2003, Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth, Am J Physiol Ren Physiol, 285, F861, 10.1152/ajprenal.00134.2003 Mallappallil, 2017, What do we know about opioids and the kidney?, Int J Mol Sci, 18, 223, 10.3390/ijms18010223 Alinejad, 2016, Nephrotoxicity of methadone: a systematic review, SpringerPlus, 5, 2087, 10.1186/s40064-016-3757-1 Carvalho, 2002, Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells, Arch Toxicol, 76, 581, 10.1007/s00204-002-0381-3 Faria, 2020, Drinking to death: hyponatraemia induced by synthetic phenethylamines, Drug Alcohol Depend, 212, 108045, 10.1016/j.drugalcdep.2020.108045 Adebamiro, 2012, Recurrent acute kidney injury following bath salts intoxication, Am J Kidney Dis, 59, 273, 10.1053/j.ajkd.2011.10.012 Vaz, 2020, The interplay between autophagy and apoptosis mediates toxicity triggered by synthetic cathinones in human kidney cells, Toxicol Lett, 331, 42, 10.1016/j.toxlet.2020.05.025 Luciano, 2014, Nephrotoxic effects of designer drugs: synthetic is not better, Nat Rev Nephrol, 10, 314, 10.1038/nrneph.2014.44 Dargan, 2014, Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice, Clin Toxicol, 52, 176, 10.3109/15563650.2014.892605 Peng, 2014, Suspected ketamine-associated lower urinary tract symptoms, Urol J, 11, 1508 Ou, 2020, Risk of renal function decline in patients with ketamine-associated uropathy, Int J Environ Res Publ Health, 17, 7260, 10.3390/ijerph17197260 Leung, 2020, Urological effects of ketamine abuse Van Laecke, 2017, Smoking and chronic kidney disease: seeing the signs through the smoke?, Nephrol Dial Transplant, 32, 403, 10.1093/ndt/gfw448 Jain, 2013, Nicotine signaling and progression of chronic kidney disease in smokers, Biochem Pharmacol, 86, 1215, 10.1016/j.bcp.2013.07.014 Xia, 2017, Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies, Nephrol Dial Transplant, 32, 475, 10.1093/ndt/gfw452 Drummond, 2016, Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosis, Physiol Genom, 48, 950, 10.1152/physiolgenomics.00070.2016 Roehm, 2017, Cigarette smoking attenuates kidney protection by angiotensin-converting enzyme inhibition in nondiabetic chronic kidney disease, Am J Nephrol, 46, 260, 10.1159/000481206 Begum, 2018, Possible role of nicotine and cotinine on nitroxidative stress and antioxidant content in saliva of smokeless tobacco consumers, Pract. Lab. Med., 12 Parente Filho, 2020, Kidney disease associated with androgenic–anabolic steroids and vitamin supplements abuse: Be aware, Nefrologia, 40, 26, 10.1016/j.nefro.2019.06.003 Pope, 2014, The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates, Am J Addict, 23, 371, 10.1111/j.1521-0391.2013.12118.x Merino García, 2018, Kidney damage due to the use of anabolic androgenic steroids and practice of bodybuilding, Nefrologia, 38, 101, 10.1016/j.nefro.2017.03.004 El-Reshaid, 2018, Complementary bodybuilding: a potential risk for permanent kidney disease, Saudi J. Kidney Dis. Transplant., 29, 326, 10.4103/1319-2442.229269 Herlitz, 2010, Development of focal segmental glomerulosclerosis after anabolic steroid abuse, J Am Soc Nephrol, 21, 163, 10.1681/ASN.2009040450 Loh, 2017, Effects of gonadectomy and testosterone treatment on aquaporin expression in the kidney of normotensive and hypertensive rats, Exp Biol Med, 242, 1376, 10.1177/1535370217703360 Perazella, 2018, Pharmacology behind common drug nephrotoxicities, Clin J Am Soc Nephrol, 13, 1897, 10.2215/CJN.00150118